During this webinar, Thomas Hanke, EVP Head of Academic Partnerships at Evotec in Germany, will present his vision and experience on how the preclinical validation of translational academic research projects should be planned and executed, in relationship with its foreseen clinical applications.
Evotec is a biotechnology company that offers technological expertise to advance drug discovery and development in a co-creation model with pharmaceutical companies, biotechs, foundations, and government agencies; as well as CRO/CDMO services for the Biopharma R&D sector.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Exciting training, even after almost 10 hours I am curious about more experience and knowledge.
Petr Suchomel
Palacký University Olomouc, Czech Republic
Excellent professional gathering, perfect collection of topics and very up-to-date insight.
Ludovic Urgeghe
University of Mons, Belgium
The event had something to offer all members of the TT community from entry level to mid-career and beyond.
John Gleeson
University of Limerick, Ireland
This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.
Ram Siddappa
Erasmus MC, Netherlands
The course exceeded my expectations. We exchanged experiences and learned different options of approaches to existing problems.
Patricia Lima
Instituto Superior Technico, Portugal
Join our newsletter and get the latest news